PFI-4
CAS No. 900305-37-5
PFI-4( PFI-4 | PFI 4 | PFI4 )
Catalog No. M16470 CAS No. 900305-37-5
A potent, selective inhibitor of the BRPF1 bromodomain with pIC50 of 7.3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 54 | In Stock |
|
| 10MG | 71 | In Stock |
|
| 25MG | 146 | In Stock |
|
| 50MG | 284 | In Stock |
|
| 100MG | 495 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePFI-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective inhibitor of the BRPF1 bromodomain with pIC50 of 7.3.
-
DescriptionA potent, selective inhibitor of the BRPF1 bromodomain with pIC50 of 7.3; exhibits >100-fold selectivity for BRPF1 over a panel of other bromodomains including BRPF2 (BRD1), BRPF3 and BRD4.
-
In VitroPFI-4 (1.25 μM; 7 or 11 days) inhibits differentiation of human osteoclasts. Cell Viability Assay Cell Line:Osteoclasts Concentration:1.25 μM Incubation Time:7 or 11 days Result:Significantly reduces MMP9 secretion in osteoclasts.
-
In Vivo——
-
SynonymsPFI-4 | PFI 4 | PFI4
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorBRPF1|BRPF2|BRPF3
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number900305-37-5
-
Formula Weight380.4402
-
Molecular FormulaC21H24N4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 26 mg/mL
-
SMILESO=C(NC1=C(N2CCCC2)C=C(N3C)C(N(C)C3=O)=C1)C4=CC=CC=C4OC
-
Chemical NameBenzamide, N-[2,3-dihydro-1,3-dimethyl-2-oxo-6-(1-pyrrolidinyl)-1H-benzimidazol-5-yl]-2-methoxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Demont EH, et al. ACS Med Chem Lett. 2014 Sep 10;5(11):1190-5.
molnova catalog
related products
-
BET inhibitor CF53
BET inhibitor CF53 is a highly potent, orally active inhibitor of bromodomain and extra-terminal (BET) with Ki of <1 nM (BRD4 BD1).
-
BAY-850
BAY-850 (BAY 850, BAY850) is a potent, isoform selective, cellularly active ATAD2 bromodomain inhibitor with binding IC50 of 166 nM in TR-FRET assay.
-
GNE-207
GNE-207 (GNE207) is a novel potent, selective, orally active CBP/p300 bromodomain with IC50 of 1.0 nM.
Cart
sales@molnova.com